Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Net revenue:
Revenue		$ 447,605	$ 429,909	$ 396,289
Cost of revenue:
Total cost of revenue	[1]	293,645	269,954	236,782
Gross profit		153,960	159,955	159,507
Operating expenses:
Research and development	[2]	57,129	57,752	52,729
Selling and marketing		46,178	49,664	42,820
General and administrative		48,271	44,391	41,723
Total operating expenses		151,578	151,807	137,272
Income from operations		2,382	8,148	22,235
Income on equity method investment		2,572	241	872
Other expense, net		(11,742)	(10,391)	(27,666)
Total loss before provision for income taxes		(6,788)	(2,002)	(4,559)
Provision for income taxes		2,492	3,345	1,752
Net loss		$ (9,280)	$ (5,347)	$ (6,311)
Earnings Per Share, Basic		$ (0.1)	$ (0.06)	$ (0.07)
Earnings Per Share, Diluted		$ (0.1)	$ (0.06)	$ (0.07)
Weighted average common shares used in computing net income (loss) per share:
Basic		94,884	92,095	92,031
Diluted		94,884	92,095	92,031
Net Income (Loss)		$ (9,280)	$ (5,347)	$ (6,311)
Foreign currency translation adjustment		(791)	(3,998)	1,705
Change in defined benefit pension obligation		(1,193)	4,311	872
Comprehensive loss		(11,264)	(5,034)	(3,734)
Products
Net revenue:
Revenue	[3]	233,192	214,715	176,647
Cost of revenue:
Total cost of revenue		153,627	127,287	102,100
Services
Net revenue:
Revenue	[4]	214,413	215,194	219,642
Cost of revenue:
Total cost of revenue		$ 140,018	$ 142,667	$ 134,682

[1] Includes cost of revenue from sales to the joint venture, an equity method investment, of $37,772 during the year ended June 30, 2023, $35,237 during the year ended June 30, 2022, and $13,310 during the year ended June 30, 2021, respectively. See Note 11.

[2] Includes charge backs to the joint venture, an equity method investment, related to research and development of $1,463 during the year ended June 30, 2023, $2,336 during the year ended June 30, 2022, and $430 during the year ended June 30, 2021, respectively.

[3] Includes sales of products to the joint venture, an equity method investment, of $55,658 during the year ended June 30, 2023, $45,545 during the year ended June 30, 2022, and $12,033 during the year ended June 30, 2021, respectively. See Note 11.

[4] Includes sales of services to the joint venture, an equity method investment, of $10,919 during the year ended June 30, 2023, $10,332 during the year ended June 30, 2022, and $12,360 during the year ended June 30, 2021, respectively. See Note 11.